XML 35 R12.htm IDEA: XBRL DOCUMENT v2.4.0.8
STOCK BASED COMPENSATION
9 Months Ended
Sep. 30, 2014
STOCK BASED COMPENSATION  
STOCK BASED COMPENSATION

NOTE 6 — STOCK BASED COMPENSATION

 

2014 Omnibus Incentive Plan

 

In January 2014, our board of directors approved the 2014 Omnibus Incentive Plan and amended and restated the plan in March 2014. Our stockholders approved the Amended and Restated 2014 Omnibus Incentive Plan, or the 2014 Plan, in March 2014. Our 2014 Plan permits for the issuance of equity based instruments covering up to an initial total of 1,400,000 shares of common stock.

 

Option Valuation

 

We have computed the fair value of options granted using the Black-Scholes option valuation model. Option forfeitures are estimated at the time of valuation and reduce expense ratably over the vesting period. This estimate will be adjusted periodically based on the extent to which actual option forfeitures differ, or are expected to differ, from the previous estimate, when it is material. The expected term used for options issued to non-employees is the contractual life and the expected term used for options issued to employees is the estimated period of time that options granted are expected to be outstanding. We utilized the “simplified” method to develop an estimate of the expected term of “plain vanilla” employee option grants. Since our stock has not been publicly traded for a sufficiently long period of time, we are utilizing an expected volatility figure based on a review of the historical volatilities, over a period of time, equivalent to the expected life of the instrument being valued, of similarly positioned public companies within its industry. The risk-free interest rate was determined from the implied yields from U.S. Treasury zero-coupon bonds with a remaining term consistent with the expected term of the instrument being valued.

 

Stock Options

 

On September 4, 2014 and September 11, 2014, we granted incentive stock options for the purchase of 15,000 shares and 30,000 shares, respectively, of our common stock to two new employees. The options have an exercise price of $6.79 per share and $6.49 per share, respectively, with a term of ten years. The options vest quarterly over sixteen quarters. The options had an aggregate grant date fair value of $174,900 utilizing the Black-Scholes option valuation model.

 

We estimated the fair value of stock options awarded during the three and nine months ended September 30, 2014 using the Black-Scholes option valuation model. The fair values of stock options granted for the period were estimated using the following assumptions:

 

 

 

Option Grants
Awarded During the
Three Months
Ended September 30, 2014

 

Option Grants
Awarded During the
Nine Months
Ended September 30, 2014

 

Stock Price

 

$6.49 to $6.79

 

$6.00 to $7.20

 

Dividend Yield

 

0%

 

0%

 

Expected Volatility

 

56.6% - 57.5%

 

56.6% - 69.8%

 

Risk-free interest rate

 

2.46% - 2.56%

 

2.01% - 2.56%

 

Expected Life

 

7 years

 

6.93 to 7 years

 

 

Stock-based compensation expense related to stock options for both employees and non-employees was $98,108 and $559,684, for the three and nine months ended September 30, 2014, respectively, and was $0 for both the three and nine months ended September 30, 2013. For the three and nine months ended September 30, 2014, stock-based compensation related to stock options of $42,284 and $253,038, respectively, was reflected in research and development and $55,824 and $306,646, respectively, was reflected in general and administrative expenses on the accompanying condensed consolidated statements of operations. As of September 30, 2014, the unamortized portion will be expensed over a weighted average period of 3.2 years. We also recorded $46,751 and $96,263 of stock-based compensation related to the 5,145 and 10,174 restricted stock unit shares that vested during the three and nine months ended September 30, 2014, respectively. For the three and nine months ended September 30, 2014, stock-based compensation expense related to restricted stock unit shares of $32,346 and $65,171, respectively, was reflected in research and development and $14,405 and $31,092, respectively, was reflected in general and administrative expenses on the accompanying condensed consolidated statements of operations. The shares issued were net of employee related withholding taxes paid with shares.

 

Stock Option Award Activity

 

The following is a summary of our stock option activity during the nine months ended September 30, 2014:

 

 

 

Number of
Options

 

Weighted
Average
Exercise
Price

 

Weighted
Average
Grant Date
Fair Value

 

Weighted
Average
Remaining
Life In
Years

 

Value

 

Outstanding, January 1, 2014

 

 

$

 

$

 

 

$

 

Granted

 

421,500

 

6.00

 

4.03

 

9.70

 

1,701,315

 

Exercised

 

 

 

 

 

 

Forfeited

 

 

 

 

 

 

Outstanding, September 30, 2014

 

421,500

 

$

6.00

 

$

4.03

 

9.70

 

$

1,701,315

 

 

 

 

 

 

 

 

 

 

 

 

 

Exercisable, January 1, 2014

 

 

$

 

$

 

 

$

 

Vested

 

124,892

 

6.00

 

4.01

 

9.70

 

559,684

 

Exercised

 

 

 

 

 

 

Forfeited

 

 

 

 

 

 

Exercisable, September 30, 2014

 

124,892

 

$

6.00

 

$

4.01

 

9.70

 

$

559,684

 

 

The following table presents information related to stock options outstanding and exercisable at September 30, 2014:

 

Options Outstanding

 

Options Exercisable

 

Exercise
Price

 

Outstanding
Number of
Options

 

Weighted
Average
Remaining
Life In
Years

 

Exercisable
Number
of Options

 

$

 6.00

 

364,000

 

9.67

 

124,572

 

6.49 – 6.79

 

45,000

 

9.94

 

 

7.20

 

12,500

 

9.75

 

320

 

 

 

421,500

 

9.70

 

124,892

 

 

Stock-based compensation consists of the following:

 

 

 

For the  Three
Months Ended
September 30, 2014

 

For the  Nine
Months Ended
September 30, 2014

 

Employees

 

$

107,248

 

$

381,356

 

Consultants/Advisors

 

48,241

 

274,533

 

 

 

$

155,489

 

$

655,889